Nodular regenerative hyperplasia causing portal hypertension in a patient with chronic graft versus host disease: response to sirolimus

Acta Haematol. 2014;132(1):49-52. doi: 10.1159/000356736. Epub 2014 Jan 15.

Authors

Hannah Choe¹, Ibrahim Aldoss, Preeti Chaudhary, John Donovan, Lydia Petrovic, Vinod Pullarkat

Affiliation

¹ Jane Ann Nohl Division of Hematology, University of Southern California, Los Angeles, Calif., USA.

PMID: 24434665
DOI: 10.1159/000356736

No abstract available

Publication types

Case Reports
Review

MeSH terms

Chronic Disease
Graft vs Host Disease / complications*
Graft vs Host Disease / drug therapy*
Hematopoietic Stem Cell Transplantation / adverse effects
Humans
Hyperplasia
Hypertension, Portal / drug therapy*
Hypertension, Portal / etiology*
Immunosuppressive Agents / therapeutic use*
Liver / drug effects
Liver / pathology*
Liver Regeneration / drug effects
Male
Middle Aged
Sirolimus / therapeutic use*

Substances

Immunosuppressive Agents
Sirolimus